Impurities Analysis

The increasing global consumption of pharmaceutical products has raised concerns about the potential health risks associated with unknown impurities ingested alongside these medications. Identifying, quantifying, and controlling these impurities has become a critical challenge, as regulatory agencies establish stringent guidelines for impurity control in both drug substances and products.
Impurities exhibit diverse chemical properties, necessitating the use of various analytical equipment such as LC-MS/MS, UHPLC, GC-MS, GC-MS/MS, and ICP-MS in laboratories. Shimadzu, a trusted scientific partner, offers tailored workflows and compliance platforms designed for the pharmaceutical industry to address impurity analysis effectively.